These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 28079388)

  • 1. [Effect of EUDRAGIT® RS on the release behaviour of theophylline solid dispersions].
    Orugun O; Oyi A; Olowosulu A; Apeji Y; Olayemi O
    Ceska Slov Farm; 2016; 65(6):226-231. PubMed ID: 28079388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of formulation and process variables on in vitro release of theophylline from directly-compressed Eudragit matrix tablets.
    Ceballos A; Cirri M; Maestrelli F; Corti G; Mura P
    Farmaco; 2005; 60(11-12):913-8. PubMed ID: 16129436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eudraginated polymer blends: a potential oral controlled drug delivery system for theophylline.
    Emeje M; John-Africa L; Isimi Y; Kunle O; Ofoefule S
    Acta Pharm; 2012 Mar; 62(1):71-82. PubMed ID: 22472450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation, characterization and in vitro evaluation of theophylline-loaded Eudragit RS 100 microspheres prepared by an emulsion-solvent diffusion/evaporation technique.
    Jelvehgari M; Barar J; Valizadeh H; Shadrou S; Nokhodchi A
    Pharm Dev Technol; 2011; 16(6):637-44. PubMed ID: 20722498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of acryclic and metacrylic acid derivatives as sustained release matrices for theophylline hydrate tablets.
    Ofoefule SI; Chukwu A
    Boll Chim Farm; 1999 Nov; 138(10):526-30. PubMed ID: 10765469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of an enteric polymer on drug release rates of theophylline from pellets coated with Eudragit RS 30D.
    Wu C; McGinity JW
    Pharm Dev Technol; 2003; 8(1):103-10. PubMed ID: 12665203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and characterization of metoprolol controlled-release solid dispersions.
    Varshosaz J; Faghihian H; Rastgoo K
    Drug Deliv; 2006; 13(4):295-302. PubMed ID: 16766471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of proteins to minimize the physical aging of EUDRAGIT sustained release films.
    Kucera SA; McGinity JW; Zheng W; Shah NH; Malick AW; Infeld MH
    Drug Dev Ind Pharm; 2007 Jul; 33(7):717-26. PubMed ID: 17654020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organic solution versus aqueous dispersion of Eudragit RS in preparation of sustained release microparticles of theophylline using spray drying.
    Garekani HA; Moghaddam ZF; Sadeghi F
    Colloids Surf B Biointerfaces; 2013 Aug; 108():374-9. PubMed ID: 23602991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Permeability and swelling studies on free films containing inulin in combination with different polymethacrylates aimed for colonic drug delivery.
    Akhgari A; Farahmand F; Afrasiabi Garekani H; Sadeghi F; Vandamme TF
    Eur J Pharm Sci; 2006 Jul; 28(4):307-14. PubMed ID: 16713201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coatings from blends of Eudragit® RL and L55: a novel approach in pH-controlled drug release.
    Wulff R; Leopold CS
    Int J Pharm; 2014 Dec; 476(1-2):78-87. PubMed ID: 25239771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of film additives on stabilizing drug release rates from pellets coated with acrylic polymers.
    Maejima T; McGinity JW
    Pharm Dev Technol; 2001; 6(2):211-21. PubMed ID: 11416995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of extended-release solid dispersions of nonsteroidal antiinflammatory drugs with aqueous polymeric dispersions: optimization of drug release via a curve-fitting technique.
    Ho C; Hwang GC
    Pharm Res; 1992 Feb; 9(2):206-10. PubMed ID: 1553343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo evaluation of gliclazide push-pull osmotic pump coated with aqueous colloidal polymer dispersions.
    Tang X; Tai LY; Yang XG; Chen F; Xu HM; Pan WS
    Drug Dev Ind Pharm; 2013 Jan; 39(1):67-76. PubMed ID: 22339718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and evaluation of gastroretentive raft forming systems incorporating curcumin-Eudragit® EPO solid dispersions for gastric ulcer treatment.
    Kerdsakundee N; Mahattanadul S; Wiwattanapatapee R
    Eur J Pharm Biopharm; 2015 Aug; 94():513-20. PubMed ID: 26143367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of an acrylic polymer blend on the physical stability of film-coated theophylline pellets.
    Kucera S; Shah NH; Malick AW; Infeld MH; McGinity JW
    AAPS PharmSciTech; 2009; 10(3):864-71. PubMed ID: 19568939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation optimization of solid dispersion of mosapride hydrochloride.
    Kim HJ; Lee SH; Lim EA; Kim JS
    Arch Pharm Res; 2011 Sep; 34(9):1467-75. PubMed ID: 21975808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of hydroxyethylcellulose on the drug release properties of theophylline pellets coated with Eudragit RS 30 D.
    Zheng W; Sauer D; McGinity JW
    Eur J Pharm Biopharm; 2005 Jan; 59(1):147-54. PubMed ID: 15567312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering polymer blend microparticles: an investigation into the influence of polymer blend distribution and interaction.
    Alhnan MA; Basit AW
    Eur J Pharm Sci; 2011 Jan; 42(1-2):30-6. PubMed ID: 20950685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and characterization of solid dispersion-microsphere controlled release system for poorly water-soluble drug.
    Malipeddi VR; Dua K; Awasthi R
    Drug Deliv Transl Res; 2016 Oct; 6(5):540-50. PubMed ID: 27343081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.